PACBPACIFIC BIOSCIENCES OF CALI...

Nasdaq pacb.com


$ 1.78 $ 0.05 (2.91 %)    

Friday, 10-May-2024 15:58:27 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 1.77
$ 1.72
$ 0.00 x 0
$ 0.00 x 0
$ 1.68 - $ 1.90
$ 1.25 - $ 14.55
13,433,567
na
477.15M
$ 2.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-03-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 02-28-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-03-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-05-2018 09-30-2018 10-Q
24 08-03-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-26-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 05-05-2017 03-31-2017 10-Q
30 03-06-2017 12-31-2016 10-K
31 11-04-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 03-11-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 05-05-2015 03-31-2015 10-Q
38 03-12-2015 12-31-2014 10-K
39 11-05-2014 09-30-2014 10-Q
40 08-05-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-equal-weight-on-pacific-biosciences-lowers-price-target-to-2

Barclays analyst Luke Sergott maintains Pacific Biosciences (NASDAQ:PACB) with a Equal-Weight and lowers the price target fr...

 pacbio-expects-to-reduce-non-gaap-annualized-expense-run-rate-by-more-than-75m-by-end-of-2024-vs-initial-guidance-of-5-growth-in-2024-operating-expenses

Initiated activities to reduce annualized run-rate operating expenses and the Company expects to achieve above the high end of ...

 pacific-biosciences-q1-2024-adj-eps-026-beats-028-estimate-sales-38810m-miss-42962m-estimate

Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $...

 jp-morgan-downgrades-pacific-biosciences-to-neutral

JP Morgan analyst Rachel Vatnsdal downgrades Pacific Biosciences (NASDAQ:PACB) from Overweight to Neutral.

 goldman-sachs-maintains-neutral-on-pacific-biosciences-lowers-price-target-to-25

Goldman Sachs analyst Matthew Sykes maintains Pacific Biosciences (NASDAQ:PACB) with a Neutral and lowers the price target f...

 bernstein-maintains-outperform-on-pacific-biosciences-lowers-price-target-to-25

Bernstein analyst Eve Burstein maintains Pacific Biosciences (NASDAQ:PACB) with a Outperform and lowers the price target fro...

 goldman-sachs-downgrades-pacific-biosciences-to-neutral-lowers-price-target-to-25

Goldman Sachs analyst Matthew Sykes downgrades Pacific Biosciences (NASDAQ:PACB) from Buy to Neutral and lowers the price ta...

 scotiabank-maintains-sector-outperform-on-pacific-biosciences-lowers-price-target-to-8

Scotiabank analyst Sung Ji Nam maintains Pacific Biosciences (NASDAQ:PACB) with a Sector Outperform and lowers the price tar...

 td-cowen-maintains-buy-on-pacific-biosciences-lowers-price-target-to-25

TD Cowen analyst Daniel Brennan maintains Pacific Biosciences (NASDAQ:PACB) with a Buy and lowers the price target from $12 ...

 why-invo-bioscience-shares-are-trading-higher-by-around-73-here-are-20-stocks-moving-premarket

Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.

 sp-500-edges-lower-pacbio-shares-plunge

U.S. stocks traded mixed toward the end of trading, with the S&P 500 falling around 0.3% on Tuesday. The Dow traded up 0.0...

 why-skillsoft-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter...

 gold-moves-higher-morgan-stanley-earnings-top-views

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 0.2% on Tuesday. The Dow traded up 0...

 dow-gains-over-100-points-bank-of-america-posts-upbeat-profit

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION